Researchers test drug safety in people with liver issues
NCT ID NCT03289234
Summary
This study aimed to understand how a drug called MCI-186 is processed by the body in people with mild or moderate liver problems compared to people with normal liver function. It involved 22 participants who received a single dose of the drug. The goal was to gather safety information to guide future dosing for patients with liver conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Fukuoka, Japan
-
Investigational site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.